The very first blood test for Alzheimer's disease detection has been green-lit by the US Food and Drug Administration (FDA), ...

The FDA has approved the first blood test to detect early Alzheimer’s replacing invasive scans Learn how this game-changing tool could transform diagnosis and treatment ...

The FDA has granted 510(k) marketing clearance to the first in vitro blood-based biomarker diagnostic device for Alzheimer’s ...

The US Food and Drug Administration (FDA) has approved Fujirebio Diagnostics’ Alzheimer’s disease (AD) blood test to help ...

Fujirebio Diagnostics Inc.’s Alzheimer’s disease assay received the U.S. FDA’s first clearance for a blood test for the ...

The test has a complicated name: The Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio. But the goal of the test, created by ...

The US Food and Drug Administration has cleared the first-ever blood test for diagnosing Alzheimer's disease, offering a less ...

The test is for those aged 55 and older who are already exhibiting signs and symptoms of the disease, the FDA says.

The FDA cleared the first blood test intended to help in diagnosing Alzheimer’s, marking a significant step in making diagnosis more accessible and less invasive. The test is designed for adults 55 ...

However, that could all change thanks to a new blood test called Lumipulse. On May 16, the U.S. Food & Drug Administration ...

The first blood test for Alzheimer is now FDA-approved. Learn how it helps early detection. Stay informed and act early—read ...